chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fibrin D dimer, Gait disturbance, Inflammation
Clinical narrative: Trouble walking due to the swollen inflammation on my foot.; Trouble walking due to the swollen inflammation on my foot.; Trouble walking due to the swollen inflammation on my foot.; Pain on the bottom of my feet/Pain on fingers; Pain on knee; Migraine headache; Chills; Fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine headache), GAIT DISTURBANCE (Trouble walking due to the swollen inflammation on my foot.), PERIPHERAL SWELLING (Trouble walking due to the swollen inflammation on my foot.), PAIN IN EXTREMITY (Pain on the bottom of my feet/Pain on fingers) and INFLAMMATION (Trouble walking due to the swollen inflammation on my foot.) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and APIXABAN (ELIQUIS) for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced MIGRAINE (migraine headache), CHILLS (chills), PYREXIA (Fever) and NAUSEA (Nausea). On 11-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain on the bottom of my feet/Pain on fingers) and ARTHRALGIA (Pain on knee). On an unknown date, the patient experienced GAIT DISTURBANCE (Trouble walking due to the swollen inflammation on my foot.), PERIPHERAL SWELLING (Trouble walking due to the swollen inflammation on my foot.) and INFLAMMATION (Trouble walking due to the swollen inflammation on my foot.). At the time of the report, MIGRAINE (migraine headache), GAIT DISTURBANCE (Trouble walking due to the swollen inflammation on my foot.), PERIPHERAL SWELLING (Trouble walking due to the swollen inflammation on my foot.), PAIN IN EXTREMITY (Pain on the bottom of my feet/Pain on fingers), INFLAMMATION (Trouble walking due to the swollen inflammation on my foot.), CHILLS (chills), PYREXIA (Fever), NAUSEA (Nausea) and ARTHRALGIA (Pain on knee) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Fibrin D dimer: high (High) too high.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient went to doctor and was told to take Eliquis.  Action taken with mRNA-1273 in response to the event was not applicable .   This case was linked to MOD-2021-238916 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Nausea, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: Trouble walking due to the swollen inflammation on my foot.; Trouble walking due to the swollen inflammation on my foot.; Trouble walking due to the swollen inflammation on my foot.; Pain on the bottom of my feet/Pain on fingers; Pain on knee; Migraine headache; Chills; Fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine headache), GAIT DISTURBANCE (Trouble walking due to the swollen inflammation on my foot.), PERIPHERAL SWELLING (Trouble walking due to the swollen inflammation on my foot.), PAIN IN EXTREMITY (Pain on the bottom of my feet/Pain on fingers) and INFLAMMATION (Trouble walking due to the swollen inflammation on my foot.) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and APIXABAN (ELIQUIS) for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced MIGRAINE (migraine headache), CHILLS (chills), PYREXIA (Fever) and NAUSEA (Nausea). On 11-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain on the bottom of my feet/Pain on fingers) and ARTHRALGIA (Pain on knee). On an unknown date, the patient experienced GAIT DISTURBANCE (Trouble walking due to the swollen inflammation on my foot.), PERIPHERAL SWELLING (Trouble walking due to the swollen inflammation on my foot.) and INFLAMMATION (Trouble walking due to the swollen inflammation on my foot.). At the time of the report, MIGRAINE (migraine headache), GAIT DISTURBANCE (Trouble walking due to the swollen inflammation on my foot.), PERIPHERAL SWELLING (Trouble walking due to the swollen inflammation on my foot.), PAIN IN EXTREMITY (Pain on the bottom of my feet/Pain on fingers), INFLAMMATION (Trouble walking due to the swollen inflammation on my foot.), CHILLS (chills), PYREXIA (Fever), NAUSEA (Nausea) and ARTHRALGIA (Pain on knee) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Fibrin D dimer: high (High) too high.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient went to doctor and was told to take Eliquis.  Action taken with mRNA-1273 in response to the event was not applicable .   This case was linked to MOD-2021-238916 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Incorrect route of product administration
Clinical narrative: subcutaneous injection; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (subcutaneous injection) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (subcutaneous injection). At the time of the report, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (subcutaneous injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medication was reported. No treatment medication was reported.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Swelling
Clinical narrative: Swelling; Severe Hip pain; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling) and ARTHRALGIA (Severe Hip pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling) and ARTHRALGIA (Severe Hip pain). At the time of the report, SWELLING (Swelling) and ARTHRALGIA (Severe Hip pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Head discomfort, Myalgia, Pyrexia
Clinical narrative: Heavy head; Had chills; Had body aches; Had fever of 99 degrees under the arm; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (Heavy head), CHILLS (Had chills), MYALGIA (Had body aches) and PYREXIA (Had fever of 99 degrees under the arm) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. C10A21A and 03L20A) for COVID-19 vaccination.     No medical history were reported. .    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jun-2021, the patient experienced CHILLS (Had chills). 26-Jun-2021, the patient experienced MYALGIA (Had body aches) and PYREXIA (Had fever of 99 degrees under the arm). On 28-Jun-2021, the patient experienced HEAD DISCOMFORT (Heavy head). On 28-Jun-2021, HEAD DISCOMFORT (Heavy head), CHILLS (Had chills), MYALGIA (Had body aches) and PYREXIA (Had fever of 99 degrees under the arm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jun-2021, Body temperature: 99.0 (normal) 99.0 Degrees.         No concomitant medications were reported. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: I had my first shot on May 3rd 2021. I haven't had the second one yet. It was due 31st May; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I had my first shot on May 3rd 2021. I haven't had the second one yet. It was due 31st May) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (I had my first shot on May 3rd 2021. I haven't had the second one yet. It was due 31st May). On 31-May-2021, PRODUCT DOSE OMISSION ISSUE (I had my first shot on May 3rd 2021. I haven't had the second one yet. It was due 31st May) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Abdominal pain lower
Clinical narrative: Right side about 4" below belly button a dull ache; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN LOWER (Right side about 4" below belly button a dull ache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jun-2021, the patient experienced ABDOMINAL PAIN LOWER (Right side about 4" below belly button a dull ache). At the time of the report, ABDOMINAL PAIN LOWER (Right side about 4" below belly button a dull ache) outcome was unknown.              No concomitant medications were reported. Treatment information was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Adverse event; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Adverse event) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Adverse event). At the time of the report, ADVERSE EVENT (Adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was not provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Heart rate, Hyperhidrosis
Clinical narrative: started to sweat a lot; felt week; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (started to sweat a lot) and ASTHENIA (felt week) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (started to sweat a lot) and ASTHENIA (felt week). At the time of the report, HYPERHIDROSIS (started to sweat a lot) and ASTHENIA (felt week) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: high (High) increase.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications are provided. treatment to the events not reported.   Reporter did not allow further contact
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Nausea, Nervousness
Clinical narrative: anxiety attacks; feeling nervous; nausea without vomiting; This spontaneous case was reported by a non-health professional and describes the occurrence of ANXIETY (anxiety attacks), NERVOUSNESS (feeling nervous) and NAUSEA (nausea without vomiting) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 18-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANXIETY (anxiety attacks), NERVOUSNESS (feeling nervous) and NAUSEA (nausea without vomiting). The patient was treated with LORAZEPAM for Anxiety, at an unspecified dose and frequency. At the time of the report, NERVOUSNESS (feeling nervous) and NAUSEA (nausea without vomiting) outcome was unknown.            No concomitant medication was reported.   This case was linked to MOD-2021-100492 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow-up received: Outcome of anxiety was updated.
Sex: U
Vaccine: COVID19
Symptoms: Laryngitis
Clinical narrative: Laryngitis; This spontaneous case was reported by a consumer and describes the occurrence of LARYNGITIS (Laryngitis) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LARYNGITIS (Laryngitis). At the time of the report, LARYNGITIS (Laryngitis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.    Reporter did not allow further contact
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Antiphospholipid antibodies, Arthralgia, Capillary fragility, Erythema, Fatigue
Clinical narrative: Pressure in back; spider vein; capillaries  that burst; red arm; petechiae outburst; muscle twitch; Stiff neck; Hearing issue; missed second dose; Head numbness; covid arm; brain fog; fatigue; swollen lymph; joint pain on left knee,; arm pain/Muscle pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries  that burst), ERYTHEMA (red arm) and PETECHIAE (petechiae outburst) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries  that burst), ERYTHEMA (red arm), PETECHIAE (petechiae outburst), MUSCLE TWITCHING (muscle twitch), MUSCULOSKELETAL STIFFNESS (Stiff neck), HEARING DISABILITY (Hearing issue), PRODUCT DOSE OMISSION ISSUE (missed second dose), HYPOAESTHESIA (Head numbness), VACCINATION COMPLICATION (covid arm), FEELING ABNORMAL (brain fog), FATIGUE (fatigue), LYMPHADENOPATHY (swollen lymph), ARTHRALGIA (joint pain on left knee,), MYALGIA (arm pain/Muscle pain) and HEADACHE (Headache). The patient was treated with DOXYCYCLINE for Petechiae, at an unspecified dose and frequency; METHYLPREDNISOLONE for Swollen lymph nodes, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (BABY ASPIRIN) at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries  that burst), ERYTHEMA (red arm), PETECHIAE (petechiae outburst), MUSCLE TWITCHING (muscle twitch), MUSCULOSKELETAL STIFFNESS (Stiff neck), HEARING DISABILITY (Hearing issue), HYPOAESTHESIA (Head numbness), VACCINATION COMPLICATION (covid arm), FEELING ABNORMAL (brain fog), FATIGUE (fatigue), LYMPHADENOPATHY (swollen lymph), ARTHRALGIA (joint pain on left knee,), MYALGIA (arm pain/Muscle pain) and HEADACHE (Headache) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (missed second dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Antiphospholipid antibodies: positive (Positive) Positive.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Pep scan came normal. No concomitant medications were reported by the reporter. Treatment mediations includes Advil and 2 compression devices were used.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Hearing disability, Hypoaesthesia, Lymphadenopathy
Clinical narrative: Pressure in back; spider vein; capillaries  that burst; red arm; petechiae outburst; muscle twitch; Stiff neck; Hearing issue; missed second dose; Head numbness; covid arm; brain fog; fatigue; swollen lymph; joint pain on left knee,; arm pain/Muscle pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries  that burst), ERYTHEMA (red arm) and PETECHIAE (petechiae outburst) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries  that burst), ERYTHEMA (red arm), PETECHIAE (petechiae outburst), MUSCLE TWITCHING (muscle twitch), MUSCULOSKELETAL STIFFNESS (Stiff neck), HEARING DISABILITY (Hearing issue), PRODUCT DOSE OMISSION ISSUE (missed second dose), HYPOAESTHESIA (Head numbness), VACCINATION COMPLICATION (covid arm), FEELING ABNORMAL (brain fog), FATIGUE (fatigue), LYMPHADENOPATHY (swollen lymph), ARTHRALGIA (joint pain on left knee,), MYALGIA (arm pain/Muscle pain) and HEADACHE (Headache). The patient was treated with DOXYCYCLINE for Petechiae, at an unspecified dose and frequency; METHYLPREDNISOLONE for Swollen lymph nodes, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (BABY ASPIRIN) at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries  that burst), ERYTHEMA (red arm), PETECHIAE (petechiae outburst), MUSCLE TWITCHING (muscle twitch), MUSCULOSKELETAL STIFFNESS (Stiff neck), HEARING DISABILITY (Hearing issue), HYPOAESTHESIA (Head numbness), VACCINATION COMPLICATION (covid arm), FEELING ABNORMAL (brain fog), FATIGUE (fatigue), LYMPHADENOPATHY (swollen lymph), ARTHRALGIA (joint pain on left knee,), MYALGIA (arm pain/Muscle pain) and HEADACHE (Headache) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (missed second dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Antiphospholipid antibodies: positive (Positive) Positive.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Pep scan came normal. No concomitant medications were reported by the reporter. Treatment mediations includes Advil and 2 compression devices were used.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle twitching, Musculoskeletal discomfort, Musculoskeletal stiffness, Myalgia, Petechiae
Clinical narrative: Pressure in back; spider vein; capillaries  that burst; red arm; petechiae outburst; muscle twitch; Stiff neck; Hearing issue; missed second dose; Head numbness; covid arm; brain fog; fatigue; swollen lymph; joint pain on left knee,; arm pain/Muscle pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries  that burst), ERYTHEMA (red arm) and PETECHIAE (petechiae outburst) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries  that burst), ERYTHEMA (red arm), PETECHIAE (petechiae outburst), MUSCLE TWITCHING (muscle twitch), MUSCULOSKELETAL STIFFNESS (Stiff neck), HEARING DISABILITY (Hearing issue), PRODUCT DOSE OMISSION ISSUE (missed second dose), HYPOAESTHESIA (Head numbness), VACCINATION COMPLICATION (covid arm), FEELING ABNORMAL (brain fog), FATIGUE (fatigue), LYMPHADENOPATHY (swollen lymph), ARTHRALGIA (joint pain on left knee,), MYALGIA (arm pain/Muscle pain) and HEADACHE (Headache). The patient was treated with DOXYCYCLINE for Petechiae, at an unspecified dose and frequency; METHYLPREDNISOLONE for Swollen lymph nodes, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (BABY ASPIRIN) at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries  that burst), ERYTHEMA (red arm), PETECHIAE (petechiae outburst), MUSCLE TWITCHING (muscle twitch), MUSCULOSKELETAL STIFFNESS (Stiff neck), HEARING DISABILITY (Hearing issue), HYPOAESTHESIA (Head numbness), VACCINATION COMPLICATION (covid arm), FEELING ABNORMAL (brain fog), FATIGUE (fatigue), LYMPHADENOPATHY (swollen lymph), ARTHRALGIA (joint pain on left knee,), MYALGIA (arm pain/Muscle pain) and HEADACHE (Headache) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (missed second dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Antiphospholipid antibodies: positive (Positive) Positive.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Pep scan came normal. No concomitant medications were reported by the reporter. Treatment mediations includes Advil and 2 compression devices were used.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Spider vein, Vaccination complication
Clinical narrative: Pressure in back; spider vein; capillaries  that burst; red arm; petechiae outburst; muscle twitch; Stiff neck; Hearing issue; missed second dose; Head numbness; covid arm; brain fog; fatigue; swollen lymph; joint pain on left knee,; arm pain/Muscle pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries  that burst), ERYTHEMA (red arm) and PETECHIAE (petechiae outburst) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries  that burst), ERYTHEMA (red arm), PETECHIAE (petechiae outburst), MUSCLE TWITCHING (muscle twitch), MUSCULOSKELETAL STIFFNESS (Stiff neck), HEARING DISABILITY (Hearing issue), PRODUCT DOSE OMISSION ISSUE (missed second dose), HYPOAESTHESIA (Head numbness), VACCINATION COMPLICATION (covid arm), FEELING ABNORMAL (brain fog), FATIGUE (fatigue), LYMPHADENOPATHY (swollen lymph), ARTHRALGIA (joint pain on left knee,), MYALGIA (arm pain/Muscle pain) and HEADACHE (Headache). The patient was treated with DOXYCYCLINE for Petechiae, at an unspecified dose and frequency; METHYLPREDNISOLONE for Swollen lymph nodes, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (BABY ASPIRIN) at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries  that burst), ERYTHEMA (red arm), PETECHIAE (petechiae outburst), MUSCLE TWITCHING (muscle twitch), MUSCULOSKELETAL STIFFNESS (Stiff neck), HEARING DISABILITY (Hearing issue), HYPOAESTHESIA (Head numbness), VACCINATION COMPLICATION (covid arm), FEELING ABNORMAL (brain fog), FATIGUE (fatigue), LYMPHADENOPATHY (swollen lymph), ARTHRALGIA (joint pain on left knee,), MYALGIA (arm pain/Muscle pain) and HEADACHE (Headache) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (missed second dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Antiphospholipid antibodies: positive (Positive) Positive.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Pep scan came normal. No concomitant medications were reported by the reporter. Treatment mediations includes Advil and 2 compression devices were used.
Sex: U
Vaccine: COVID19
Symptoms: Device connection issue, Incorrect dose administered, Off label use
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of device connection issue (small amount leaked out of the injection site), off-label use (needed an additional shot in the same sitting) and incorrect dose administered (possible over dose/some of the first leaked out) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Jun 25, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 25, 2021, patient experienced a device connection issue (small amount leaked out of the injection site), off-label use (needed an additional shot in the same sitting) and incorrect dose administered (possible over dose/some of the first leaked out). At the time of the report, device connection issue (small amount leaked out of the injection site), off-label use (needed an additional shot in the same sitting) and incorrect dose administered (possible over dose/some of the first leaked out) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): not applicable. No concomitant medication or treatment information reported.
Sex: U
Vaccine: COVID19
Symptoms: Rash, Swelling face
Clinical narrative: face is swollen; Rash all over body; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (face is swollen) and RASH (Rash all over body) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (face is swollen) and RASH (Rash all over body). At the time of the report, SWELLING FACE (face is swollen) and RASH (Rash all over body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment was reported. No concomitant medication was reported
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Myalgia, Vaccination site erythema, Vaccination site swelling
Clinical narrative: site is red; really swollen; muscle pain/ I am in excruciating pain from this shot; I couldn't sleep last night; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (I couldn't sleep last night), VACCINATION SITE ERYTHEMA (site is red), VACCINATION SITE SWELLING (really swollen) and MYALGIA (muscle pain/ I am in excruciating pain from this shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jun-2021 at 7:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jun-2021, the patient experienced INSOMNIA (I couldn't sleep last night) and MYALGIA (muscle pain/ I am in excruciating pain from this shot). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (site is red) and VACCINATION SITE SWELLING (really swollen). At the time of the report, INSOMNIA (I couldn't sleep last night), VACCINATION SITE ERYTHEMA (site is red), VACCINATION SITE SWELLING (really swollen) and MYALGIA (muscle pain/ I am in excruciating pain from this shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported. No Treatment information Provided.   Reporter did not allow further contact
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Erythema, Inappropriate schedule of product administration, Induration, Nausea
Clinical narrative: Infected at the injection; Nauseous; Thrown up; Bruises where the lump was; Spots all over where the lump was; Hard, not hot, knot; Red in a circle around where it swelled up; Swelled up, swelling started to go down; Hurt a little bit, but was nothing bad; 1st dose on 24-Apr-2021 and 2nd dose on 24-Jun-2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 24-Apr-2021 and 2nd dose on 24-Jun-2021), INDURATION (Hard, not hot, knot), ERYTHEMA (Red in a circle around where it swelled up), SWELLING (Swelled up, swelling started to go down) and PAIN (Hurt a little bit, but was nothing bad) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017C21A and 002C12A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 24-Apr-2021 and 2nd dose on 24-Jun-2021), ERYTHEMA (Red in a circle around where it swelled up), SWELLING (Swelled up, swelling started to go down) and PAIN (Hurt a little bit, but was nothing bad). On 25-Jun-2021, the patient experienced INDURATION (Hard, not hot, knot). On 26-Jun-2021, the patient experienced CONTUSION (Bruises where the lump was), RASH MACULAR (Spots all over where the lump was), NAUSEA (Nauseous) and VOMITING (Thrown up). On an unknown date, the patient experienced VACCINATION SITE INFECTION (Infected at the injection). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 24-Apr-2021 and 2nd dose on 24-Jun-2021), INDURATION (Hard, not hot, knot), ERYTHEMA (Red in a circle around where it swelled up), SWELLING (Swelled up, swelling started to go down), PAIN (Hurt a little bit, but was nothing bad), CONTUSION (Bruises where the lump was), RASH MACULAR (Spots all over where the lump was), VACCINATION SITE INFECTION (Infected at the injection), NAUSEA (Nauseous) and VOMITING (Thrown up) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter.  Treatment medication included She had been using ice on the area and taking an antihistamine.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rash macular, Swelling, Vaccination site infection, Vomiting
Clinical narrative: Infected at the injection; Nauseous; Thrown up; Bruises where the lump was; Spots all over where the lump was; Hard, not hot, knot; Red in a circle around where it swelled up; Swelled up, swelling started to go down; Hurt a little bit, but was nothing bad; 1st dose on 24-Apr-2021 and 2nd dose on 24-Jun-2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 24-Apr-2021 and 2nd dose on 24-Jun-2021), INDURATION (Hard, not hot, knot), ERYTHEMA (Red in a circle around where it swelled up), SWELLING (Swelled up, swelling started to go down) and PAIN (Hurt a little bit, but was nothing bad) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017C21A and 002C12A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 24-Apr-2021 and 2nd dose on 24-Jun-2021), ERYTHEMA (Red in a circle around where it swelled up), SWELLING (Swelled up, swelling started to go down) and PAIN (Hurt a little bit, but was nothing bad). On 25-Jun-2021, the patient experienced INDURATION (Hard, not hot, knot). On 26-Jun-2021, the patient experienced CONTUSION (Bruises where the lump was), RASH MACULAR (Spots all over where the lump was), NAUSEA (Nauseous) and VOMITING (Thrown up). On an unknown date, the patient experienced VACCINATION SITE INFECTION (Infected at the injection). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 24-Apr-2021 and 2nd dose on 24-Jun-2021), INDURATION (Hard, not hot, knot), ERYTHEMA (Red in a circle around where it swelled up), SWELLING (Swelled up, swelling started to go down), PAIN (Hurt a little bit, but was nothing bad), CONTUSION (Bruises where the lump was), RASH MACULAR (Spots all over where the lump was), VACCINATION SITE INFECTION (Infected at the injection), NAUSEA (Nauseous) and VOMITING (Thrown up) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter.  Treatment medication included She had been using ice on the area and taking an antihistamine.
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Confusional state, Disturbance in attention, Memory impairment
Clinical narrative: confused; drained of energy; I can't recall info that I should know; can't do two things at once; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (confused), ASTHENIA (drained of energy), MEMORY IMPAIRMENT (I can't recall info that I should know) and DISTURBANCE IN ATTENTION (can't do two things at once) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONFUSIONAL STATE (confused), ASTHENIA (drained of energy), MEMORY IMPAIRMENT (I can't recall info that I should know) and DISTURBANCE IN ATTENTION (can't do two things at once). At the time of the report, CONFUSIONAL STATE (confused), ASTHENIA (drained of energy), MEMORY IMPAIRMENT (I can't recall info that I should know) and DISTURBANCE IN ATTENTION (can't do two things at once) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment details were reported.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Lethargy, Myalgia
Clinical narrative: Lethargic; Chills; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargic), CHILLS (Chills) and MYALGIA (Sore Arm) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (BIKTARVY) for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced LETHARGY (Lethargic), CHILLS (Chills) and MYALGIA (Sore Arm). At the time of the report, LETHARGY (Lethargic), CHILLS (Chills) and MYALGIA (Sore Arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-239018 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Hyperhidrosis, Lymphadenopathy, Myalgia
Clinical narrative: sleeping all day; sweating; redness; Vomiting; Nausea; her arm started getting sore / body aches.; swelling of lymph node; extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleeping all day), HYPERHIDROSIS (sweating), ERYTHEMA (redness), VOMITING (Vomiting) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (sleeping all day), HYPERHIDROSIS (sweating), ERYTHEMA (redness), VOMITING (Vomiting), NAUSEA (Nausea), MYALGIA (her arm started getting sore / body aches.), LYMPHADENOPATHY (swelling of lymph node) and FATIGUE (extremely tired). At the time of the report, SOMNOLENCE (sleeping all day), HYPERHIDROSIS (sweating), ERYTHEMA (redness), VOMITING (Vomiting), NAUSEA (Nausea), MYALGIA (her arm started getting sore / body aches.), LYMPHADENOPATHY (swelling of lymph node) and FATIGUE (extremely tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. Patient states that 6 hours later, arm started getting sore, redness, extremely tired, and the next day she slept all day. Patient also experienced body aches, swelling of the lymph node underneath the same arm of the injection, some nausea and vomiting and sweating. HCP told her should have received something like Tylenol or Ibuprofen for the pain, aches, soreness, and nausea and vomiting. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Somnolence, Vomiting
Clinical narrative: sleeping all day; sweating; redness; Vomiting; Nausea; her arm started getting sore / body aches.; swelling of lymph node; extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleeping all day), HYPERHIDROSIS (sweating), ERYTHEMA (redness), VOMITING (Vomiting) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (sleeping all day), HYPERHIDROSIS (sweating), ERYTHEMA (redness), VOMITING (Vomiting), NAUSEA (Nausea), MYALGIA (her arm started getting sore / body aches.), LYMPHADENOPATHY (swelling of lymph node) and FATIGUE (extremely tired). At the time of the report, SOMNOLENCE (sleeping all day), HYPERHIDROSIS (sweating), ERYTHEMA (redness), VOMITING (Vomiting), NAUSEA (Nausea), MYALGIA (her arm started getting sore / body aches.), LYMPHADENOPATHY (swelling of lymph node) and FATIGUE (extremely tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. Patient states that 6 hours later, arm started getting sore, redness, extremely tired, and the next day she slept all day. Patient also experienced body aches, swelling of the lymph node underneath the same arm of the injection, some nausea and vomiting and sweating. HCP told her should have received something like Tylenol or Ibuprofen for the pain, aches, soreness, and nausea and vomiting. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Chest pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pain). At the time of the report, CHEST PAIN (Chest pain) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.  No concomitant medications were mentioned. No treatment details were reported.
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: still not feel normal; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (still not feel normal) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FEELING ABNORMAL (still not feel normal). At the time of the report, FEELING ABNORMAL (still not feel normal) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment details were reported. Patient reported that it has been 4 days since the first shot and still feeling abnormal.
Sex: U
Vaccine: COVID19
Symptoms: Dysgeusia, Menstruation irregular, Vaccination complication
Clinical narrative: disrupt your periods, missed my last 2 periods; had a lot a couple weird side affects; certain foods and drinks taste like chemicals or smell like s; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION IRREGULAR (disrupt your periods, missed my last 2 periods), VACCINATION COMPLICATION (had a lot a couple weird side affects) and DYSGEUSIA (certain foods and drinks taste like chemicals or smell like s) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENSTRUATION IRREGULAR (disrupt your periods, missed my last 2 periods), VACCINATION COMPLICATION (had a lot a couple weird side affects) and DYSGEUSIA (certain foods and drinks taste like chemicals or smell like s). At the time of the report, MENSTRUATION IRREGULAR (disrupt your periods, missed my last 2 periods), VACCINATION COMPLICATION (had a lot a couple weird side affects) and DYSGEUSIA (certain foods and drinks taste like chemicals or smell like s) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore injection site arm; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (sore injection site arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore injection site arm). On 05-Feb-2021, VACCINATION SITE PAIN (sore injection site arm) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter   This case was linked to MOD-2021-238979 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Non-significant follow up appended - Email address updated.